Follow-up of patients with mycosis fungoides after interferon α2b treatment failure

INTRODUCTION: Treatment of T cell cutaneous lymphoma( CTCL) is a controversial subject and the effectiveness of treatment is still low. AIM: Report of single center experience of management CTCL after progression after first line treatment. MATERIAL AND METHODS: We present 41 patients with CTCL, 29...

Descripción completa

Detalles Bibliográficos
Autores principales: Chmielowska, Ewa, Studziński, Maciej, Giebel, Sebastian, Krause, Anna, Olejniczak, Monika, Grzanka, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436229/
https://www.ncbi.nlm.nih.gov/pubmed/26015774
http://dx.doi.org/10.5114/pdia.2014.40941
Descripción
Sumario:INTRODUCTION: Treatment of T cell cutaneous lymphoma( CTCL) is a controversial subject and the effectiveness of treatment is still low. AIM: Report of single center experience of management CTCL after progression after first line treatment. MATERIAL AND METHODS: We present 41 patients with CTCL, 29 received interferon α2b in first line, and 12 of them received second line therapy. RESULTS: Overall response rate for second line therapy was 60%. CONCLUSIONS: Results of the follow-up of patients with mycosis fungoides after interferon α2b treatment failure with the literature review and discussion.

Ejemplares similares